Neurovista CorpCompany Details

Get alertedif Neurovista Corp gets funded!
United States
Detailed industries:medical
Company description

NeuroVista Corporation is a medical device company pioneering new technologies for the management and treatment of epilepsy, a condition that affects roughly 3 million people in the United States. The defining characteristic of epilepsy is recurrent seizures that strike without warning. Symptoms may range from brief suspension of awareness, to loss of consciousness, to violent convulsions. Unlike other neurological conditions, such as stroke or Alzheimer's disease which tend to develop later in life, epilepsy often affects people in the prime ...of their lives, with the majority between 15 and 64 years of age. Despite advancements in antiepileptic medications, an estimated 25% of people with epilepsy continue to experience seizures even when under the best medical care. The constant fear and uncertainty as to when the next seizure is going to strike often exacts a tremendous toll on the quality of life for patients and their families. People with uncontrolled seizures incur frequent injuries and are at an elevated risk of death. They are restricted from driving automobiles and are unable to safely participate in many recreational activities. Activities of daily living such as bathing or cooking are dangerous. Fear of seizures in public settings often leads to isolation and limits vocational opportunities. And risk of death from an unwitnessed and unmanaged seizure poses a significant psychological burden for patients and their caregivers. Clearly there is a need for a solution that keeps patients informed about when seizures are likely to strike and reliably alerts caregivers when seizures do strike. NeuroVista is engaged in developing an innovative Epilepsy Management System to empower both patients and caregivers with information that will make living with uncontrolled seizures more manageable. In addition, quantitative seizure data collected by the system provides physicians with the information they need for a more informed use of pharmacology. In total, the NeuroVista Epilepsy Management System provides critical information that is potentially life-saving, will significantly impact the quality of life for patients and their caregivers, and will enable a more informed use of pharmacology for controlling seizures. NeuroVista is led by an experienced management team in close collaboration with nationally recognized clinical thought-leaders and investigators. The Company is emerging as a leading innovator in the rapidly growing field of implantable neurotechnology with a large portfolio of issued patents and pending patent applications. NeuroVista closed its most recent equity financing in August of 2010 and is funded by a top-tier group of venture investors including Advanced Technology Ventures, Delphi Ventures, Foundation Medical Partners, and GBS Venture Partners. NeuroVista is headquartered in downtown Seattle, Washington. MoreLess


Funding history

DateDeal sizeInvestors 
August 20th, 2010$5,000,000-View Deal
August 20th, 2010$16,460,123-View Deal
October 7th, 2009$6,000,600-View Deal
Create alert
Want to know when Neurovista Corp gets funded?
Key people
Mike CarusiDirector, Investor
Andrew D. FirlikBoard, Boards of Directors
David DouglassDirector
Andrew FirlikDirector
Steven GourlayDirector
John HarrisDirector, Executive_Officer
Vijay LathiBoard Director
Kent LeydeCTO, Executive_Officer
Hugh MatsubayashiExecutive_Officer
Jeff StewartEngineering Project Manager
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!